Filing Details
- Accession Number:
- 0001209191-15-039405
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-06 16:05:14
- Reporting Period:
- 2015-05-04
- Filing Date:
- 2015-05-06
- Accepted Time:
- 2015-05-06 16:05:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501756 | Avalanche Biotechnologies Inc. | AAVL | Biological Products, (No Disgnostic Substances) (2836) | 205258327 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1504491 | Paul Wachter | C/O Avalanche Biotechnologies, Inc. 1035 O'Brien Drive, Suite A Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-05-04 | 1,192 | $30.87 | 44,313 | No | 4 | S | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Footnote |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,000 | Direct |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- This transaction was executed in multiple trades in prices ranging from $29.9000 to $32.0200, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The shares are held directly by the Wachter Family Trust.
Billionaire Hedge Funds
